Series Unknown Funded Startups in Denmark
Among the 50 most recent Denmark entries labeled “Series Unknown,” disclosed rounds span from a low of $290K (CS MEDICA, 2024-05-28) up to a standout $1.0B…
Among the 50 most recent Denmark entries labeled “Series Unknown,” disclosed rounds span from a low of $290K (CS MEDICA, 2024-05-28) up to a standout $1.0B (Zealand Pharma, 2024-06-25). That $1.0B deal is the only disclosed round at the billion-dollar level in this slice and is far above the rest of the disclosed amounts, which mostly cluster in the hundreds of thousands to tens of millions.
The geography is tightly concentrated: Copenhagen, Hovedstaden appears repeatedly across both biotech and health-adjacent categories (for example, IO Biotech at $60M on 2024-12-20; Dawn Health at $13M on 2025-05-05; and BioCirc at $44M on 2025-04-03). Timing also shows a front-loaded pattern in the newest months, with multiple disclosed rounds between May and August 2025 (e.g., Cellugy $9M on 2025-06-24; Wavepiston $980K on 2025-03-13; and Dancann Pharma $310K on 2025-07-09). Of the 50 rows, 39 list “undisclosed” amounts, indicating that the disclosed-size comparison is based on the remaining 11 entries.
Most recent rounds
50 shownRelated listings
Frequently asked
What does the disclosed-size range look like for the newest Denmark “Series Unknown” rounds, and how strong is the outlier effect?
The disclosed amounts run from $290K (CS MEDICA, 2024-05-28) to $1.0B (Zealand Pharma, 2024-06-25). Zealand Pharma’s $1.0B dwarfs the rest of the disclosed rounds, which mostly sit below $50M (for example, Cellugy at $9M on 2025-06-24 and BioCirc at $44M on 2025-04-03).
Do the most recent closings cluster into a specific window in 2024–2025?
Yes. Several deals land in a late-2024 to mid-2025 stretch, including a cluster in June 2024 (e.g., IO Biotech $60M on 2024-12-20 is later, but Zealand Pharma $1.0B on 2024-06-25; BioPorto Diagnostics $12M on 2024-06-18; and BioCirc $44M on 2025-04-03 show continued activity across the period). In the newest quarter shown, disclosed rounds appear in May–July 2025 such as Dawn Health $13M (2025-05-05), Cellugy $9M (2025-06-24), and Dancann Pharma $310K (2025-07-09).
Which city shows the strongest concentration of companies in this “Series Unknown” set?
Copenhagen, Hovedstaden is the most frequent location, appearing across multiple categories and sizes—for instance Dawn Health (2025-05-05, $13M), Audientes (2025-05-02, $80K), Uniqkey (2024-08-29, $6M), and IO Biotech (2024-12-20, $60M). Other cities show up but with fewer entries, such as Aarhus (e.g., Cercare Medical $8M on 2025-02-19) and Aalborg (e.g., Wavepiston $980K is in Helsingør, while Uniqkey is in Herlev and Trackunit is in Aalborg at 2025-06-16, undisclosed).
How often are amounts undisclosed, and does that limit what can be inferred from funding size?
In this page slice, 39 of 50 rows are marked “undisclosed.” As a result, most size-based conclusions must rely on the 11 disclosed entries only—where the top end is set by Zealand Pharma’s $1.0B (2024-06-25) and the bottom by CS MEDICA’s $290K (2024-05-28).
Are there sector clusters (not just one-offs) within the “Series Unknown” entries?
Biotechnology shows up repeatedly and spans widely different disclosed sizes, including Zealand Pharma at $1.0B (2024-06-25), IO Biotech at $60M (2024-12-20), Cellugy at $9M (2025-06-24), and Dancann Pharma at $310K (2025-07-09). Health Care/health-adjacent categories also appear across multiple entries such as Dawn Health ($13M, 2025-05-05), Cercare Medical ($8M, 2025-02-19), and Scandinavian Biolabs ($4M, 2024-09-18).
What are the key temporal edges in this list, and which companies define them?
The most recent round date shown is 2025-08-11, with Responsibly listed as “undisclosed.” The oldest date shown is 2024-05-02, with ExpreS2ion at $6M (2024-05-02), creating an overall span of just over a year in this 50-row snapshot.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.